BCHE and early-onset autosomal dominant Alzheimer disease: Cholinesterase inhibition, central to the cholinergic hypothesis, is associated with elevated acetylcholine levels, thereby enhancing cognitive function in Alzheimer's disease (Francis et al. 1999).